GF-GS 01: Comparing Conventional Axillary Dissection Versus Sentinel Node Resection in Clinically Node-negative Operable Breast Cancer

Hospices Civils de Lyon1,627 enrolled

Overview

Sentinel node resection appears as a promising advancement in the surgical treatment of breast cancer. The GF-GS 01 study, sponsored by a National Hospital Research Program, compares this new surgical method with a classical method in patients having a negative sentinel node. The duration of the follow-up is 5 years.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

1,627

Conditions

Breast Cancer

Interventions

Sentinel Node ResectionPROCEDURE

Sentinel Node Resection

Conventional Axillary DissectionPROCEDURE

Conventional Axillary Dissection

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 90 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Women older than 18 years with clinically node-negative operable unifocal N0 breast cancer (clinical tumour size \< 30 mm). * Written consent is obtained from all patients before randomization.

Locations (1)

Alain LEIZOROVICZ

Lyon, France

Outcomes

Primary Outcomes

Survival without recurrence

Time frame: 5 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.